This Entrepreneurship Week, University of Toronto Entrepreneurship is highlighting U of T-affiliated start-ups to keep an eye on in 2024.
HDAX Therapeutics, co-founded by alumnae Pimyupa Manaswiyoungkul and Nabanita Nawar, is looking to tackle the problem with a preventative drug that has delivered promising results in pre-clinical studies.
HDAX Therapeutics is an OBIO® member, an alumnus of the BDSP™ and WiHI Seed programs and presented at the OBIO® Investment Summit.